FerriSmart Analysis System

by Resonance Health Analysis Services Pty  · Based in Australia → — AI-Driven, Real-Time Liver Iron Quantification from MRI
Gastroenterology Hematology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

FerriSmart Analysis System is an advanced, AI-driven software-as-medical-device (SaMD) developed by Resonance Health for the automated and real-time quantification of liver iron concentration (LIC) from MRI images. Utilizing a specially trained convolutional neural network, FerriSmart analyzes R2-MRI images to provide rapid and reliable LIC reports within seconds of data upload. This non-invasive technology is a significant advancement in diagnosing and managing conditions associated with systemic iron overload.

The system is designed to simplify the process for radiologists and clinicians, allowing them to upload image data securely via a dedicated portal. FerriSmart maintains the high standards of its predecessor, FerriScan, and is compatible with a wide range of 1.5T and 3T MRI scanners. It includes an automated algorithm (IQC Module) to verify the correctness of data acquisition protocol parameters, ensuring high-quality results. FerriSmart’s results are unaffected by inflammation, fibrosis, and cirrhosis, providing consistent and accurate measurements.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated liver iron concentration (LIC) measurement
  • AI-driven analysis using convolutional neural networks
  • Real-time report generation (within seconds)
  • Non-invasive, MRI-based technology
  • Compatible with a wide range of MRI scanners (1.5T and 3T)
  • Secure data transmission via FAST portal
  • Automated quality control for image acquisition protocol adherence
  • Provides quantitative liver R2 map and LIC report
  • Results unaffected by inflammation, fibrosis, and cirrhosis

Use Cases

  • Diagnosing and managing systemic iron overload
  • Monitoring liver iron burden in transfusion-dependent thalassemia patients
  • Monitoring liver iron burden in patients with sickle cell disease receiving blood transfusions
  • Aiding in identification and monitoring of non-transfusion-dependent thalassemia patients receiving deferasirox therapy
  • Assessing drug efficacy in pharmaceutical clinical trials
  • General liver health assessment (as part of LiverSmart)

What Physicians Need to Know

Liver Iron Concentration (LIC) Measurement
FerriSmart is an automated, AI-powered system designed for the quantification of liver iron concentration (LIC) from R2-MRI images. It offers a non-invasive and painless method for assessing iron levels in the liver.
AI-Powered Analysis
The system employs a specially trained convolutional neural network to analyze R2-MRI images, enabling automated and real-time measurement of LIC.
Rapid Results
FerriSmart generates a Liver Iron Concentration report within seconds, providing clinicians with instant and reliable data to support diagnostic and treatment decisions.
Procedure Documentation
The system produces a comprehensive Liver Iron Concentration report, detailing the average LIC, 95% confidence intervals, and comparisons to normal ranges and clinically relevant thresholds, serving as essential documentation for patient management.
Quality and Accuracy
FerriSmart maintains the high standards of FerriScanu00ae, which is recognized as a global gold standard for LIC measurement. Studies have demonstrated good agreement between FerriSmart and FerriScan LIC estimates.
MRI System Compatibility
FerriSmart is compatible with a wide range of 1.5T and 3T MRI scanners for image acquisition, ensuring broad accessibility.
Physician Tip

Utilize FerriSmart for rapid and accurate assessment of liver iron concentration in patients with confirmed or suspected systemic iron overload, thalassemia, or sickle cell anemia. Integrate FerriSmart reports into patient management protocols for timely diagnosis and monitoring of iron burden, especially in conditions requiring frequent iron measurements. Leverage the real-time results to make immediate diagnostic and treatment decisions, potentially improving patient outcomes by allowing for earlier intervention or adjustment of chelation therapy. Be aware that FerriSmart requires specific MRI data acquisition protocols (FerriScan protocol) for optimal analysis.

FerriSmart operates by securely receiving DICOM files from MRI scanners, typically transmitted via a dedicated portal (e.g., FAST portal). The AI analysis is performed on a secure platform, and the results are returned electronically to the physician. The system is compatible with various MRI vendors, including Siemens, Philips, and GE, and supports both 1.5T and 3T field strengths.

Details

Category Gastroenterology AI, Radiology & Imaging AI
Pricing Contact for pricing — Not specified
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status K182218 AI-estimated

FerriSmart is FDA 510(k) cleared as a Class II medical device (K182218) for measuring liver iron concentration in individuals with confirmed or suspected systemic iron overload, monitoring liver iron burden in transfusion-dependent thalassemia patients and patients with sickle cell disease receiving blood transfusions, and aiding in the identification and monitoring of non-transfusion-dependent thalassemia patients receiving therapy with deferasirox.

Integrations
EHR Not specified
Specialties Gastroenterology, Hematology, Radiology

What the Web Says

FerriSmart Analysis System is an AI-powered medical software that automatically analyzes MRI scans of the liver to measure iron concentration, aiding in the diagnosis and monitoring of iron overload diseases like thalassemia or sickle cell disease. It provides real-time results, a significant improvement over its predecessor, FerriScan, which could take up to two business days for a report. The system has undergone extensive validation, including software verification, user usability testing, repeatability, and clinical studies, demonstrating high sensitivities and specificities.

Overall: Positive

Strengths

  • Automated, real-time analysis of MRI scans for liver iron concentration (LIC).
  • Aids in accurate and timely diagnosis and monitoring of iron overload diseases.
  • Non-invasive and painless MRI-based method.
  • High sensitivities and specificities (above 90%) for clinically relevant LIC thresholds.
  • Good agreement with FerriScan, which is considered a gold standard.
  • Reduces the need for human input and specialized training for analysis.

Limitations

  • Does not display a liver R2 map or an average R2 value, unlike FerriScan.
  • R2 methods can be insensitive for monitoring longitudinal changes in patients with severe iron overload due to the curvilinear relationship with LIC.
  • Potential for ghosting artifacts due to free-breathing acquisitions during the MRI scan.
  • Cost of FerriSmart services may not always be reimbursable by insurance.
  • Requires a specific MRI data acquisition protocol to avoid errors.
  • The effect of concomitant fat on R2 estimation is not well understood.

Based on reviews from: X-ray Interpreter, PMC, 3DR Labs, American Society of Hematology (Blood), Resonance Health, Listcorp

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate FerriSmart Analysis System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

RadAI Slice
FerriSmart Analysis System | FDA Radiology AI Device - X-ray Interpreter
FerriSmart is a medical software that automatically analyzes MRI scans of the liver to measure iron concentration, aiding in the diagnosis and monitoring of iron overload diseases. It received FDA 510(k) clearance on November 30, 2018.
2018-11
PMC (PubMed Central)
State of the Art Quantification of Liver Iron with MRI - Vendor Implementation and Available Tools - PMC
FerriSmart, an FDA-cleared technique by Resonance Health, utilizes artificial intelligence for real-time image analysis and generates liver iron concentration reports, showing good agreement with FerriScan estimates.
unknown
MDPI
Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine - MDPI
The FerriSmart Analysis System, an automated system for measuring liver iron concentration, was approved by the FDA on November 30, 2018, as a Class II (510(k)) device.
2020-11
Medical Design and Outsourcing
Understanding the Impact: FDA's Take on AI and ML in Medical Devices
The FerriSmart Analysis System by Resonance Health Analysis Service Pty Ltd. is highlighted as an integration of AI/ML-based interpretation in the Internal Medicine sector for assessing liver iron concentration.
2024-08
Exploration of Endocrine and Metabolic Diseases
Recent advances in artificial intelligence-assisted endocrinology and diabetes
The FerriSmart Analysis System (FerriScan) has been developed and approved for assessing the concentration of iron in the liver, demonstrating the application of AI in endocrinology.
2024-04
FDA
K182218 - 510(k) Premarket Notification - FDA
This FDA document details the 510(k) premarket notification for the FerriSmart Analysis System, submitted by Resonance Health Analysis Services Pty, Ltd., for measuring R2 and iron concentration in the liver from MRI scans.
2018-11
MDPI
Artificial Intelligence in Translational Medicine - MDPI
The FerriSmart Analysis System, utilizing ML/CNN, is software for measuring liver iron concentration from R2-MRI images and was approved in November 2018.
2021-11
BMJ Health & Care Informatics
How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices | BMJ Health & Care Informatics
The FerriSmart Analysis System by Resonance Health Analysis Services Pty Ltd. is listed as an FDA 510(k) Premarket Notification approved device from 2018, demonstrating the integration of machine learning in clinical decision support.
2021-04

Videos

Product demos, reviews, and walkthroughs for FerriSmart Analysis System.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

FerriSmart integrates by utilizing R2-MRI images acquired using a specific protocol on most 1.5T MRI scanners (Philips, Siemens, GE). These DICOM files are then securely transmitted via a web portal for automated AI analysis, with results returned to the physician in real-time.
FerriSmart has received FDA 510(k) clearance in the US, CE Mark in the European Union, and TGA approval in Australia, classifying it as a Software as a Medical Device (SaMD). Patient data is securely transmitted via a FAST portal, and the system is designed to minimize human error in analysis.
FerriSmart, an AI-powered system, provides automated liver iron concentration (LIC) results within seconds, significantly faster than FerriScan which can take up to two business days. While FerriScan is considered the gold standard, FerriSmart LIC estimates have shown good agreement with FerriScan, offering instant results for clinical decisions.
The specific pricing model for FerriSmart is not publicly detailed in the available information. However, it is a service provided by Resonance Health, and costs may vary depending on regional distribution partners and specific agreements.
FerriSmart's accuracy relies on images acquired with the correct MRI protocol; errors in acquisition will prevent analysis. While there is good agreement with FerriScan, FerriSmart and FerriScan should not be considered interchangeable, and R2 methods can be insensitive for monitoring longitudinal changes in patients with severe iron overload.
FerriSmart utilizes a specially trained convolutional neural network for image analysis and has undergone extensive validation. Clinical studies have assessed its performance, demonstrating good agreement and diagnostic accuracy compared to FerriScan measurements of LIC, which serves as the reference standard.

Related Tools

GI Genius Module
Cosmo Artificial Intelligence - Ai, Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is an AI-powered system designed to assist physicians in the real-time detection of colorectal polyps during colonoscopy, acting as a "second set of eyes" to enhance visualization and improve detection rates.
Cologuard / Cologuard Plus
Exact Sciences
Gastroenterology AI
Cologuard and Cologuard Plus are FDA-approved, non-invasive stool DNA colorectal cancer screening tests from Exact Sciences for average-risk individuals aged 45 and older. Cologuard Plus offers enhanced accuracy and fewer false positives. These at-home tests detect DNA markers and blood in stool to identify early-stage colorectal cancer.
Deep Capsule
Digestaid - Artificial Intelligence Development SA
Gastroenterology AI
Deep Capsule is an AI software tool that assists in reviewing capsule endoscopy images by detecting and differentiating lesions, stratifying hemorrhagic potential, and highlighting clinically relevant frames for physician validation.
Pure-Vu
Motus GI
Gastroenterology AI
The Pure-Vu System is an FDA-approved device that facilitates intra-procedural cleansing of the GI tract to improve visualization during colonoscopies and gastroscopies, especially in cases of inadequate bowel preparation or GI bleeding.
aScope Gastro
Ambu
Gastroenterology AI
The Ambu aScope Gastro is a sterile, single-use gastroscope with advanced imaging and design features for a variety of endoscopic procedures in the upper GI tract, offering portability and eliminating reprocessing.
CADDIE™ Computer-Aided Detection (CADe) Device
Odin Medical Ltd. (an Olympus Corporation company)
Clinical Decision Support & Reference
CADDIE™ is the first cloud-based AI technology to receive FDA clearance, designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures. This AI tool, developed by Odin Medical Ltd., an Olympus Corporation company, supports real-time polyp detection and characterization, improves adenoma detection rates, and integrates seamlessly into existing clinical workflows.

See all Gastroenterology AI tools →

More from Resonance Health Analysis Services

HepaFat-AI
Resonance Health Analysis Services Pty
Endocrinology & Metabolic AI
AI-driven software that automatically analyzes MRI datasets to assess liver fat in patients, providing a comprehensive multi-metric solution for fatty liver disease assessment.
HepaFatSmart
Resonance Health Analysis Services Pty
Endocrinology & Metabolic AI
HepaFatSmart is an FDA-cleared, AI-powered Software-as-a-Medical Device (SaMD) that provides automated, multi-metric assessment of liver fat from MRI scans, including VLFF, PDFF, and steatosis grade.
LiverSmart
Resonance Health Analysis Services Pty
Gastroenterology AI
LiverSmart is an AI-powered MRI-based solution from Resonance Health that combines liver iron concentration (FerriSmart) and liver fat assessment (HepaFatSmart) into a single, comprehensive report for clinicians.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.